ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    ICLP10302017 | Vitiligo
Previous Study | Return to List | Next Study

The Gut and Skin Microbiome in Vitiligo Disease Progression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03577327
Recruitment Status : Not yet recruiting
First Posted : July 4, 2018
Last Update Posted : July 4, 2018
Sponsor:
Information provided by (Responsible Party):
I Caroline Le Poole, Northwestern University

Brief Summary:
Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.

Condition or disease
Vitiligo Healthy

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Gut and Skin Microbiome in Vitiligo Disease Progression
Estimated Study Start Date : August 2018
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vitiligo

Group/Cohort
Adults with vitiligo
Healthy adults



Primary Outcome Measures :
  1. Microbiome composition [ Time Frame: 12 months ]
    Diversity analysis of microbiome samples in control subjects versus vitiligo subjects (measured by number of bacteria species/sample)

  2. Disease Progression [ Time Frame: 12 months ]
    Disease progression in control subjects versus vitiligo subjects (measured by VASI score (0-100)).


Secondary Outcome Measures :
  1. Diet History Food Frequencies [ Time Frame: 12 months ]
    Scoring from diet history food frequency questionnaires (measured by average daily food frequency scores).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 89 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Adults with or without vitiligo who are under the age of 90 years old.
Criteria

Inclusion Criteria:

  • Patients with and/or without vitiligo lesional expansion over the past year.
  • Age/sex-matched controls who do not have a diagnosis of vitiligo
  • Subjects who are age 18-89 years of age at time of enrollment
  • Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443)

Exclusion Criteria:

  • Subjects who are younger than 18 years of age or 90 years of age or older
  • Subjects who are unable to give consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03577327


Contacts
Contact: Dermatology CTU 312-503-5944 NUdermatologyCTU@northwestern.edu

Sponsors and Collaborators
Northwestern University
Investigators
Principal Investigator: I. Caroline Le Poole Northwestern University

Responsible Party: I Caroline Le Poole, Professor, Northwestern University
ClinicalTrials.gov Identifier: NCT03577327     History of Changes
Other Study ID Numbers: ICLP10302017
First Posted: July 4, 2018    Key Record Dates
Last Update Posted: July 4, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Disease Progression
Vitiligo
Disease Attributes
Pathologic Processes
Hypopigmentation
Pigmentation Disorders
Skin Diseases